New drug JPH034 enters first human safety tests
NCT ID NCT07534657
First seen Jun 27, 2026 · Last updated Aug 07, 2026 · Updated 2 times
Summary
This early-stage study is testing whether a new drug, JPH034, is safe for people. About 40 healthy adults aged 18 to 50 will receive either the drug or a placebo. Researchers will monitor side effects and measure how the drug moves through the body. This study does not aim to treat any disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTH ADULT SUBJECTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Axis Clinicals Phase 1 Unit
RECRUITINGDilworth, Minnesota, 56529, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can the right work-rest rhythm and a massage gun soften stiff calf muscles?
- Beetroot boost: does more nitrate mean more endurance?
- What makes people move? new study probes the secrets of physical activity
- New daily pill TIX100 takes first step toward tackling obesity
- New skin ointment takes first step toward treating inflammatory conditions
- One yoga session may boost heart health overnight